CL2007002928A1 - Polimorfo b de n-{2-fluoro-5-[3-(tiofen-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]-fenil}-n-metil-acetamida; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de ansiedad, epilepsia, trastornos del sueno, - Google Patents

Polimorfo b de n-{2-fluoro-5-[3-(tiofen-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]-fenil}-n-metil-acetamida; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de ansiedad, epilepsia, trastornos del sueno,

Info

Publication number
CL2007002928A1
CL2007002928A1 CL200702928A CL2007002928A CL2007002928A1 CL 2007002928 A1 CL2007002928 A1 CL 2007002928A1 CL 200702928 A CL200702928 A CL 200702928A CL 2007002928 A CL2007002928 A CL 2007002928A CL 2007002928 A1 CL2007002928 A1 CL 2007002928A1
Authority
CL
Chile
Prior art keywords
thiofen
pirazolo
fenyl
epilepsy
pyrimidin
Prior art date
Application number
CL200702928A
Other languages
English (en)
Inventor
Anglada Albert Palomer An Luis
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37789824&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007002928(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of CL2007002928A1 publication Critical patent/CL2007002928A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CL200702928A 2006-10-11 2007-10-11 Polimorfo b de n-{2-fluoro-5-[3-(tiofen-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]-fenil}-n-metil-acetamida; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de ansiedad, epilepsia, trastornos del sueno, CL2007002928A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06122138A EP1918290A1 (en) 2006-10-11 2006-10-11 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide

Publications (1)

Publication Number Publication Date
CL2007002928A1 true CL2007002928A1 (es) 2008-05-09

Family

ID=37789824

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200702928A CL2007002928A1 (es) 2006-10-11 2007-10-11 Polimorfo b de n-{2-fluoro-5-[3-(tiofen-2-carbonil)-pirazolo[1,5-a]pirimidin-7-il]-fenil}-n-metil-acetamida; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de ansiedad, epilepsia, trastornos del sueno,

Country Status (21)

Country Link
US (2) US8039476B2 (es)
EP (2) EP1918290A1 (es)
JP (1) JP5171831B2 (es)
KR (1) KR101418624B1 (es)
CN (1) CN101622257B (es)
AR (1) AR063231A1 (es)
AU (1) AU2007306319B2 (es)
BR (1) BRPI0717833A2 (es)
CA (1) CA2666653C (es)
CL (1) CL2007002928A1 (es)
DK (1) DK2081935T3 (es)
ES (1) ES2637137T3 (es)
MX (1) MX2009003571A (es)
NO (1) NO342008B1 (es)
PL (1) PL2081935T3 (es)
PT (1) PT2081935T (es)
RU (1) RU2413729C2 (es)
SI (1) SI2081935T1 (es)
TW (1) TWI391392B (es)
UY (1) UY30637A1 (es)
WO (1) WO2008043800A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1921079A1 (en) * 2006-11-08 2008-05-14 Ferrer Internacional, S.A. Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
US9209332B2 (en) * 2008-03-31 2015-12-08 Kyocera Corporation Solar cell element and solar cell module
IT1391113B1 (it) * 2008-09-30 2011-11-18 Dipharma Francis Srl Procedimento per la preparazione di azelnidipina cristallina

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US399621A (en) * 1889-03-12 Canning-house truck
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
BR0014459A (pt) * 1999-09-02 2002-07-16 Neurocrine Biosciences Inc Polìmeros de n-metil-n- (3-{3-[2-tienilcarbonil]-pirazol-[1,5-"alfa"]-pirimidin-7-il } fenil) acetamida e composições e métodos relacionados aos mesmos
KR101063033B1 (ko) * 2002-08-26 2011-09-07 뉴로크린 바이오사이언시즈 인코퍼레이티드 Ｎ-메틸-Ｎ-(3-(3-[2-티에닐카르보닐]-피라졸-[1,5-α]-피리미딘-7-일)페닐)아세트아미드의 신규한 동질이상체 및 그와 관련된 조성물 및 방법
US7304069B2 (en) * 2004-10-18 2007-12-04 Neurocrine Biosciences, Inc. Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Also Published As

Publication number Publication date
AR063231A1 (es) 2009-01-14
SI2081935T1 (sl) 2017-12-29
NO342008B1 (no) 2018-03-12
KR20090077796A (ko) 2009-07-15
US20110224234A1 (en) 2011-09-15
JP5171831B2 (ja) 2013-03-27
PT2081935T (pt) 2017-08-29
BRPI0717833A2 (pt) 2014-06-10
RU2009117716A (ru) 2010-11-20
US8273753B2 (en) 2012-09-25
TW200827360A (en) 2008-07-01
NO20091625L (no) 2009-05-07
AU2007306319A1 (en) 2008-04-17
EP2081935B1 (en) 2017-05-24
RU2413729C2 (ru) 2011-03-10
KR101418624B1 (ko) 2014-07-15
CN101622257B (zh) 2013-03-27
UY30637A1 (es) 2008-05-02
EP1918290A1 (en) 2008-05-07
US8039476B2 (en) 2011-10-18
US20100087451A1 (en) 2010-04-08
TWI391392B (zh) 2013-04-01
AU2007306319B2 (en) 2012-12-06
WO2008043800A1 (en) 2008-04-17
PL2081935T3 (pl) 2018-04-30
EP2081935A1 (en) 2009-07-29
ES2637137T3 (es) 2017-10-11
CA2666653A1 (en) 2008-04-17
DK2081935T3 (en) 2017-09-04
CA2666653C (en) 2014-12-30
MX2009003571A (es) 2009-04-14
CN101622257A (zh) 2010-01-06
JP2010505914A (ja) 2010-02-25

Similar Documents

Publication Publication Date Title
CL2007001882A1 (es) Compuestos derivados de imidazopirimidina; proceso para preparar los compuestos; composicion farmaceutica; y uso para la prevencion y/o tratamiento de desordenes cognitivos.
CL2007001881A1 (es) Compuestos derivados de imidazopirimidina; proceso para preparar los compuestos; composicion farmaceutica; y uso para la prevencion y/o tratamiento de desordenes cognitivos.
CL2007002169A1 (es) Compuestos derivados de n-(amino-heteroaril)-1h-indol-2-carboxamidas; procedimiento de preparacion; compuestos intermediarios; composicion farmaceutica; y uso del compuesto para prevenir o tratar la inflamacion, trastornos urologicos, gastrointestina
CL2007002974A1 (es) Compuestos derivados de benzoimidazol; composicion farmaceutica; y uso para el tratamiento de trastornos asociados con dgat1.
CL2007003832A1 (es) Compuestos derivados de azaespiro; procedimiento de preparacion; composicion farmaceutica; y su uso para prevenir y tratar ansiedad, trastornos depresivos, entre otras enfermedades.
CR10245A (es) "nuevas combinaciones terapéuticas para el tratamiento de la depresión"
HK1166983A1 (zh) 包含用於治療疾病或紊亂的化合物的固體形式，其組合物，及其用途
CL2008000180A1 (es) Sal tosilato de trans-n-etil-3-fluoro-3-[3-fluoro-4-(pirrolidin-1-ilmetil)fenil]ciclobutanocarboxamida; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como depresion, trastornos del sueno, ansiedad y enfermedades del tracto
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
CL2007002920A1 (es) Compuestos derivados de 2-aminocarbonilpiridina; composicion farmaceutica; y uso para el tratamiento de trastornos vasculares oclusivos.
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
CL2007002708A1 (es) Compuestos derivados de pirrolo[2,3-b]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, caquexia, trastornos inflamatorios, entre otros.
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
CL2008000127A1 (es) Compuestos derivados de n-(heteroaril)-1-heteroaril-1h-indol-2-carboxamidas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del dolor, inflamacion, trastornos urologicos
BRPI0818799A2 (pt) Composições para o tratamento da doença de parkinson
IL185546A0 (en) N - (n - sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain
CL2007002121A1 (es) Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab
BRPI1009252A2 (pt) composto, pró-droga, composição farmacêutica, métodos para prevenir ou tratar doenças do sistema nervoso central, e mal de alzheimer, e, uso do composto ou de uma pró-droga do mesmo
CL2007003733A1 (es) Compuestos derivados de indolin-2-ona, bencimidazol-2-ona y benzoxazol-2-ona, moduladores de serina palmitoiltransferasa; composicion farmaceutica; y uso para el tratamiento de enfermedades tales como diabetes tipo 1 y 2, obesidad, aterosclerosis, hi
BRPI0816255A2 (pt) Produto farmacêutico, uso do produto, método para a profilaxia ou o tratamento de doenças, e, composição farmaceuticamente aceitável
CL2008000641A1 (es) Compuestos derivados de amidas sustituidas; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del insomnio, disfuncion sexual, esquizofrenia, entre otras enferme
SI2205244T1 (sl) Postopki dajanja N-(5-terc.-butil-izoksazol-3-il)-N'-(4-(7-(2-morfolin- 4-il-etoksi-)imidazo-2,1-b)-(1,3)-benzotiazol-2-il)-fenil)sečnine za zdravljenje proliferativne bolezni
CL2008000318A1 (es) Compuestos derivados de n-(2,3,4,4a,5,6-hexahidro-1h-pirazino(1,2-a)quinolina-8-carbonil)bencenosulfonamida; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso para tratar el cancer de vejiga, cerebro, m
BRPI0818267A2 (pt) Novos derivados de 1,3-dihidro-5-isobenzofuranocarbonitrila e composição farmacêutica dos mesmos para o tratamento de ejaculação precoce
TWI369988B (en) New pharmaceutically active compounds for the treatment of respiratory diseases